All Stories

  1. A technique to localize posteriorly located spinal dural leaks associated with spontaneous intracranial hypotension: Dorsal-decubitus dynamic CT myelography
  2. Silent brain infarct in migraine: Systematic review and meta-analysis
  3. Pathogenic SCN2A variants are associated with familial and sporadic hemiplegic migraine
  4. Case report: Meningitis: a cause of reversible cerebral vasoconstriction syndrome?
  5. Reversible cerebral Vasoconstriction syndrome intERnational CollaborativE (REVERCE) network: Study protocol and rationale of a multicentre research collaboration
  6. Complications of reversible cerebral vasoconstriction syndrome in relation to age
  7. Genetics of migraine: where are we now?
  8. Outcomes among patients with primary angiitis of the CNS: A Nationwide United States analysis
  9. European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure
  10. The teaching of headache medicine in France: A questionnaire‐based study
  11. Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data
  12. Diagnostic utility of T2*-weighted GRE in migraine with aura attack. The cortical veins sign
  13. Systematic Review and Meta-analysis of Acute Treatments for Episodic Migraine in Adults
  14. Hemiplegic Migraine Associated With PRRT2 Variations
  15. Outcomes Among Patients With Reversible Cerebral Vasoconstriction Syndrome: A Nationwide United States Analysis
  16. Genetics of migraine
  17. Revised guidelines of the French Headache Society for the diagnosis and management of migraine in adults. Part 1: Diagnosis and assessment
  18. Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 2: Pharmacological treatment
  19. Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 3: Non-pharmacological treatment
  20. Foreword
  21. Type of headache at onset and risk for complications in reversible cerebral vasoconstriction syndrome
  22. Diagnosis and management of migraine in ten steps
  23. Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance
  24. Burden and Attitude to Resistant and Refractory Migraine A Survey From the European Headache Federation With the Endorsement of the European Migraine & Headache Alliance
  25. Severe migraine and its control: A proposal for definitions and consequences for care
  26. Mechanical Thrombectomy in Nighttime Hours: Is There a Difference in 90-Day Clinical Outcome for Patients with Ischemic Stroke?
  27. Oral steroids for episodic cluster headache
  28. Circulating microRNAs Associated With Reversible Cerebral Vasoconstriction Syndrome
  29. Acute retinal arterial ischaemia: silent brain infarcts prevalence and short‐term recurrence
  30. European headache federation consensus on the definition of resistant and refractory migraine
  31. Long-Term Outcomes After Reversible Cerebral Vasoconstriction Syndrome
  32. Concomitant reversible cerebral vasoconstriction syndrome and transient global amnesia
  33. A Clinico-Radiological Study of Cerebral Amyloid Angiopathy-Related Inflammation
  34. Reversible giant arachnoid granulations
  35. Primary angiitis of the CNS and reversible cerebral vasoconstriction syndrome
  36. Recommandations pour le diagnostic et la prise en charge de la névralgie trigéminale classique
  37. Migraine with brainstem aura: Why not a cortical origin?
  38. French guidelines for diagnosis and treatment of classical trigeminal neuralgia (French Headache Society and French Neurosurgical Society)
  39. Reversible Cerebral Vasoconstriction Syndrome Without Typical Thunderclap Headache
  40. The Link Between Migraine, Reversible Cerebral Vasoconstriction Syndrome and Cervical Artery Dissection
  41. The Typical Thunderclap Headache of Reversible Cerebral Vasoconstriction Syndrome and its Various Triggers
  42. Occipital neuralgia heralding occipital condyle syndrome revealing vesical leiomyosarcoma skull base metastasis
  43. Recurrence of Migraine With Aura After a 24-year Free Period Following rTMS Treatment for Fibromyalgia Pain
  44. Headache arising from idiopathic changes in CSF pressure
  45. Are migraineurs naturally born “well-hearted”?
  46. Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection
  47. RCVS and CVT
  48. Comment: Reversible cerebral vasoconstriction syndrome can hit twice
  49. La migraine joue-t-elle sur les vaisseaux ?
  50. Génétique des céphalées1
  51. Ischaemic Strokes with Reversible Vasoconstriction and without Thunderclap Headache: A Variant of the Reversible Cerebral Vasoconstriction Syndrome?
  52. Sindrome di vasocostrizione cerebrale reversibile
  53. Recommandations pour le diagnostic et le traitement de l’algie vasculaire de la face
  54. La vasodilatation a-t-elle un rôle dans la migraine ? Commentaires
  55. Le syndrome post-ponction lombaire. Revue de la littérature et expérience des urgences céphalées
  56. Reversible cerebral vasoconstriction syndrome and treatment with monoamine oxidase inhibitor
  57. Carotid paraganglioma mimicking a cluster headache
  58. Familial hemiplegic migraine: A model for the genetic studies of migraine
  59. Phénotypes de l’aura migraineuse
  60. Céphalée du naufrage, une entité absente de la nouvelle classification ICHD-3
  61. Reversible Cerebral Vasoconstriction Syndrome
  62. Subarachnoid and intra-cerebral hemorrhage in young adults: Rare and underdiagnosed
  63. Reversible cerebral vasoconstriction syndrome
  64. Physiopathologie et génétique de la migraine
  65. Reversible cerebral vasoconstriction syndrome and cervical artery dissection in 20 patients
  66. The International Classification of Headache Disorders, 3rd edition (beta version)
  67. Génétique de la migraine
  68. L37. Reversible cerebral vasoconstriction syndrome: Distinction from CNS vasculitis
  69. Nouvelle approche pharmacologique des traitements de fond
  70. Occipital Injections for Trigemino-Autonomic Cephalalgias: Evidence and Uncertainties
  71. Migraine et céphalée de tension : ce que doit connaître le rhumatologue
  72. CERVCO, Centre de référence des maladies vasculaires rares du cerveau et de l’oeil
  73. Thunderclap headache
  74. Migraine, Genetics
  75. Use of cannabis among 139 cluster headache sufferers
  76. Reversible cerebral vasoconstriction syndrome
  77. Emotional Status, Perceived Control of Pain, and Pain Coping Strategies in Episodic and Chronic Cluster Headache
  78. Anne Ducros
  79. Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trial
  80. Use of Antimigraine Treatments by General Practitioners
  81. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management
  82. Headache Attributed to Giant Cell (Temporal) Arteritis
  83. Reversible Cerebral Vasoconstriction Syndromes
  84. Acute Headache in the Emergency Department
  85. Hemorrhagic Manifestations of Reversible Cerebral Vasoconstriction Syndrome
  86. De novo mutations in ATP1A2 and CACNA1A are frequent in early-onset sporadic hemiplegic migraine
  87. Génétique de la migraine
  88. Reversible cerebral vasoconstriction syndrome in two patients with a carotid glomus tumour
  89. Le syndrome de vasoconstriction cérébrale réversible
  90. Syndrome de vasoconstriction cérébrale réversible
  91. Acute headache in the emergency department
  92. Reversible cerebral vasoconstriction syndrome
  93. Génétique des céphalées
  94. Emergency Treatment of Migraine
  95. Postpartum Cervicocephalic Artery Dissection
  96. Migraine hémiplégique familiale et sporadique
  97. Cluster headache
  98. Aspects cliniques et radiologiques du syndrome de vasoconstriction cérébrale réversible. Une série prospective de 67 patients
  99. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients
  100. Most Cases Labeled as ???Retinal Migraine??? Are Not Migraine
  101. Hemiplegic Migraine: Clinical Features, Links with Basilar-type Migraine, Current and Future Treatment
  102. Late-onset eosinophilic chronic meningitis occurring 30 years after Taenia solium infestation in a white Caucasian woman
  103. Chronic Paroxysmal Hemicrania in a Patient with a Macroprolactinoma
  104. Physiopathologie et approche g??n??tique de la migraine
  105. Migraine
  106. Treating Depression in Children and Adolescents
  107. ATP1A2 mutations in 11 families with familial hemiplegic migraine
  108. A Negative D-Dimer Assay Does Not Rule Out Cerebral Venous Thrombosis: A Series of Seventy-Three Patients
  109. Céphalées en coup de tonnerre
  110. Démarche diagnostique et thérapeutique dans 40 cas d’hypotension intracrânienne spontanée
  111. Early epidural blood patch in spontaneous intracranial hypotension
  112. Migraine hémiplégique familiale
  113. Migraine ophtalmique ou migraine avec aura visuelle
  114. Familial Cluster Headache: A Series of 186 Index Patients
  115. The Genetics of Migraine
  116. Absence of linkage to 8q24 in a European family with familial adult myoclonic epilepsy (FAME)
  117. Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis
  118. The Clinical Spectrum of Familial Hemiplegic Migraine Associated with Mutations in a Neuronal Calcium Channel
  119. Sporadic late onset paroxysmal cerebellar ataxia in four unrelated patients: a new disease?
  120. Missense CACNA1A Mutation Causing Episodic Ataxia Type 2
  121. Mutations de CACNA1A et migraine hémiplégique familiale.
  122. Genetics of familial hemiplegic migraine
  123. CACNA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophy
  124. Decreased hemispheric water mobility in hemiplegic migraine related to mutation of CACNA1A gene
  125. Migraine and ataxias
  126. Recurrent Episodes of Coma: An Unusual Phenotype of Familial Hemiplegic Migraine with Linkage to Chromosome 1
  127. High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2
  128. Recurrence of the T666M Calcium Channel CACNA1A Gene Mutation in Familial Hemiplegic Migraine with Progressive Cerebellar Ataxia
  129. Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity
  130. Notch3 Mutations in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL), a Mendelian Condition Causing Stroke and Vascular Dementia
  131. HEREDITARY PAROXYSMAL ATAXIAS
  132. A Human Homolog of Bacterial Acetolactate Synthase Genes Maps within the CADASIL Critical Region
  133. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia
  134. Monozygotic twins discordant for familial hemiplegic migraine
  135. A gene for hereditary paroxysmal cerebellar ataxia maps to chromosome 19p
  136. Migraine, Genetics
  137. Emotional Status, Perceived Control of Pain, and Pain Coping Strategies in Episodic and Chronic Cluster Headache